Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual role of nitric oxide in Alzheimer's disease
Ali Azargoonjahromi
Nitric Oxide (2023) Vol. 134-135, pp. 23-37
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence
Ali Azargoonjahromi, Fatemeh Abutalebian
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer’s disease mouse model, as revealed by spatial transcriptomics
Anna Mallach, Magdalena Zielonka, Veerle van Lieshout, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114216-114216
Open Access | Times Cited: 15
The duality of amyloid-β: its role in normal and Alzheimer’s disease states
Ali Azargoonjahromi
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Increased Neuronal Nitric Oxide Synthase in Alzheimer's Disease Mediates Spontaneous Calcium Signaling and Divergent Glutamatergic Calcium Responses
Rachelle Balez, Claire H. Stevens, Kerstin Lenk, et al.
Antioxidants and Redox Signaling (2024) Vol. 41, Iss. 4-6, pp. 255-277
Closed Access | Times Cited: 6
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
Ali Azargoonjahromi
Clinical Drug Investigation (2024) Vol. 44, Iss. 7, pp. 471-493
Closed Access | Times Cited: 6
Neuroprotective role of Epigallocatechin-3-Gallate, Albeginin and Melanoxetin in Alzheimer's Disease
Arif Malik, Mehreen Hassan, Sulayman Waquar, et al.
Phytomedicine Plus (2025), pp. 100740-100740
Open Access
The molecular mechanism of nitric oxide in memory consolidation and its role in the pathogenesis of memory-related disorders
Zainab I. Bahdar, Ejlal Abu‐El‐Rub, Rawan Almazari, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Open Access
Endophytic Fungal Terpenoids: Biosynthesis and Biological Activity
Juan M. Galindo-Solís, Francisco J. Fernández
(2025), pp. 261-299
Closed Access
Immune cells: Mediators in the metabolites and Alzheimer’s disease
Erdong Zhang, Fengqiu Dai, Ling Tao, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Behavioral and histological study on the neuroprotective effect of thymoquinone on the cerebellum in AlCl3-induced neurotoxicity in rats through modulation of oxidative stress, apoptosis, and autophagy
Amira I. Shrief, Dina S Elshenawy, Ahmed E. Elsukary, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 2
Closed Access
Effect of N-Acetyl Cysteine as an Adjuvant Treatment in Alzheimer’s Disease
Sarah Monserrat Lomelí Martínez, Fermín Paul Pacheco‐Moisés, Oscar Kurt Bitzer-Quintero, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 164-164
Open Access
A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer’s disease
Arduino A. Mangoni, Angelo Zinellu
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access
Secondary Metabolites of the Lichen Lethariella cladonioides and Their Neuroprotective Potential
Lei Zhang, Wen-Hua Chao, Cui-Cui Tan, et al.
Journal of Natural Products (2025)
Closed Access
Plasma tryptophan levels are linked to hippocampal integrity and cognitive function in individuals with mild cognitive impairment
Ali Azargoonjahromi
Brain Imaging and Behavior (2025)
Closed Access
Dysregulated Neurotransmission and the Role of Viruses in Alzheimer’s Disease
Katherine Bovis, Martha Davies-Branch, Philip J. Day
ACS Chemical Neuroscience (2025)
Open Access
Harnessing Passive Pulsatile Shear Stress for Alzheimer’s Disease Prevention and Intervention
José A. Adams, Arkady Uryash, José R. López
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 2, pp. 387-401
Open Access | Times Cited: 2
Novelties on Neuroinflammation in Alzheimer’s Disease–Focus on Gut and Oral Microbiota Involvement
Cristina Popescu, Constantin Munteanu, Aurelian Anghelescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11272-11272
Open Access | Times Cited: 2
Circulating arginine metabolites in Alzheimer’s disease and vascular dementia: A systematic review and meta-analysis
Angelo Zinellu, Sara Tommasi, Stefania Sedda, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102139-102139
Open Access | Times Cited: 6
Role of the SARS-CoV-2 Virus in Brain Cells
Ali Azargoonjahromi
Viral Immunology (2024) Vol. 37, Iss. 2, pp. 61-78
Closed Access | Times Cited: 1
Constitutive NOS Production Is Modulated by Alzheimer’s Disease Pathology Depending on APOE Genotype
Chiara Giuseppina Bonomi, Alessandro Martorana, Denise Fiorelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3725-3725
Open Access | Times Cited: 1
PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE
Phool Chandra, Vikas Sharma
INDIAN DRUGS (2024) Vol. 61, Iss. 07, pp. 7-22
Closed Access | Times Cited: 1
Correlations of Blood and Brain NMR Metabolomics with Alzheimer’s Disease Mouse Models
Leo L. Cheng, Franz Knörnschild, Ella Zhang, et al.
Research Square (Research Square) (2024)
Open Access
​​​Inhibition of neuroinflammation and neuronal damage by the selective non-steroidal ERβ agonist AC-186​​
Folashade O. Katola, Misturah Adana, Olumayokun A. Olajide
(2024)
Closed Access
High-Density Lipoprotein (HDL) Subtypes Adversely Alter Brain Structure in Mild Cognitive Impairment: A Tensor-Based Morphometry Analysis
Ali Azargoonjahromi, Mitra Ashrafi, Donya Abroushan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study
Mohammad Sadeghi, Ali Azargoonjahromi, Hamide Nasiri, et al.
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top